Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study reports a case of anaplastic transformation from a well-differentiated thyroid carcinoma in a young patient. The first recurrent tissue contained poorly differentiated foci that revealed lower thyroglobulin, thyroid transcription factor 1 (TTF-1), and galectin-3 expression than the well-differentiated area. However there was no increased p53 or Ki-67 expression in the poorly differentiated foci, nor in the well-differentiated area. The tissue subsequently relapsed and revealed only anaplastic features, complete loss of thyroglobulin, TTF-1, and galectin-3 expression and revealed an increase in p53 and Ki-67 expression. The BRAF V600E and BRAF V600V mutation were found in the initially diagnosed papillary thyroid carcinoma and the poorly differentiated foci of the recurring papillary thyroid carcinoma; however, only the BRAF V600V mutation was found in the anaplastic carcinoma. These results suggest that overexpression of p53 and Ki-67 contributed to the anaplastic transformation. We also found that the BRAF type changed during the tumor relapse.
Abstract
This study reports a case of anaplastic transformation from a well-differentiated thyroid carcinoma in a young patient. The first recurrent tissue contained poorly differentiated foci that revealed lower thyroglobulin, thyroid transcription factor 1 (TTF-1), and galectin-3 expression than the well-differentiated area. However there was no increased p53 or Ki-67 expression in the poorly differentiated foci, nor in the well-differentiated area. The tissue subsequently relapsed and revealed only anaplastic features, complete loss of thyroglobulin, TTF-1, and galectin-3 expression and revealed an increase in p53 and Ki-67 expression. The BRAF V600E and BRAF V600V mutation were found in the initially diagnosed papillary thyroid carcinoma and the poorly differentiated foci of the recurring papillary thyroid carcinoma; however, only the BRAF V600V mutation was found in the anaplastic carcinoma. These results suggest that overexpression of p53 and Ki-67 contributed to the anaplastic transformation. We also found that the BRAF type changed during the tumor relapse.
참고문헌 (14)
- Tan RK, "Anaplastic carcinoma of the thyroid: a 24-year experience", Head Neck, 17, pp.41~47 (1995)
- Togashi S, "Thyroid anaplastic carcinoma transformed from papillary carcinoma in extrathyroid area", Auris Nasus Larynx, 31, pp.287~292 (2004)
- Tallini G, "Poorly differentiated thyroid carcinoma. Are we there yet?", Endocr Pathol, 22, pp.190~194 (2011)
- Yeo MK, "Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules", Clin Endocrinol, 75, pp.555~560 (2011)
- Al-Qsous W, "Anaplastic transformation in lung metastases of differentiated papillary thyroid carcinoma: an autopsy case report and review of the literature", Ann Diagn Pathol, 14, pp.41~43 (2010)
- Are C, "Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches", Ann Surg Oncol, 13, pp.453~464 (2006)
- Todd WU 4th, "Thyroid follicular epithelial cell-derived carcinomas: an overview of the pathology of primary and recurrent disease", Otolaryngol Clin North Am, 41, pp.1079~1094 (2008)
- Ozaki O, "Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study", J Surg Oncol, 70, pp.45~48 (1999)
- Ito Y, "High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid", Pathology, 38, pp.545~547 (2006)
- 박지영, "BRAF and RAS Mutations in Follicular Variants of Papillary Thyroid Carcinoma", ENDOCRINE PATHOLOGY, 24(2), pp.69~76 (2013), HUMANA PRESS INC
- 김욱연, "A Case of Multifocal Papillary Thyroid Carcinoma Consisting of One Encapsulated Follicular Variant with BRAF K601E Mutation and Three Conventional Types with BRAF V600E Mutation", Journal of Pathology and Translational Medicine, 47(3), pp.293~298 (2013), 대한병리학회[DOI]
- Bansal M, "Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma", Am J Surg Pathol, 37, pp.1586~1591 (2013)
- Bahadoran P, "Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma", J Clin Oncol, 31, pp.e324~e326 (2013)
- Mao C, "KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer", PLoS One, 7, pp.e36653~ (2012)